InspireMD
NSPR
3 hedge funds and large institutions have $448K invested in InspireMD in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
32% more capital invested
Capital invested by funds: $339K → $448K (+$109K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$65.7K |
| 2 |
Renaissance Technologies
New York
|
+$65.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$54K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$54K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15K |
| 5 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
-$1K |
NSPR Hedge Fund Activity: Q4 2016 in Review
3 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2016, worth a combined $448K — up 32% from $339K a quarter earlier.
Fund positioning in NSPR was balanced in Q4 2016: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Credit Suisse, opening a new position worth an estimated $65.7K. The largest seller was Sabby Management, exiting entirely with an estimated $54K sold.
- 3 institutional investors held InspireMD (NSPR) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $448K of InspireMD stock for Q4 2016, up 32% quarter-over-quarter.
- 2 funds opened new InspireMD positions in Q4 2016 and 2 closed out, a net change of 0 holders.
- The largest InspireMD buyer in Q4 2016 was Credit Suisse, an estimated $65.7K added.
- The largest InspireMD seller in Q4 2016 was Sabby Management, an estimated $54K sold.
Based on aggregated 13F filings for Q4 2016.